Skip to main content
Notice2026-20115

Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Title-Recordkeeping for the Transfer of Electronic Prescriptions in Schedules III-V Between Pharmacies

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
October 1, 2026

Issuing agencies

Justice Department

Abstract

The Drug Enforcement Administration, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the Federal Register, volume 91 FR 46484, on July 23, 2026, allowing a 60-day comment period.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 189 (Thursday, October 1, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 189 (Thursday, October 1, 2026)]
[Notices]
[Pages 62560-62561]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-20115]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0061]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Revision of a Previously Approved Collection; 
Title--Recordkeeping for the Transfer of Electronic Prescriptions in 
Schedules III-V Between Pharmacies

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-day Notice.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration, Department of Justice 
(DOJ), will be submitting the following information collection request 
to the Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection was previously published in the Federal 
Register, volume 91 FR 46484, on July 23, 2026, allowing a 60-day 
comment period.

DATES: Comments are encouraged and will be accepted for 30 days until 
November 2, 2026.

FOR FURTHER INFORMATION CONTACT: If you have comments especially on the 
estimated public burden or associated response time, suggestions, or 
need a copy of the proposed information collection instrument with 
instructions or additional information, please contact: Heather E. 
Achbach, Regulatory Drafting and Policy Support Section, Drug 
Enforcement Administration; Mailing Address: 8701 Morrissette Drive, 
Springfield, Virginia 22152; Telephone: (571) 776-3882; Email: 
<a href="/cdn-cgi/l/email-protection#97d3d2d6b9c7c5d6d7f3f2f6b9f0f8e1"><span class="__cf_email__" data-cfemail="e6a2a3a7c8b6b4a7a6828387c8818990">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: 
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:
--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and/or
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.
    Written comments and recommendations for this information 
collection should be submitted within

[[Page 62561]]

30 days of the publication of this notice on the following website 
<a href="http://www.reginfo.gov/public/do/">www.reginfo.gov/public/do/</a>PRAMain. Find this particular information 
collection by selecting ``Currently under 30-day Review--Open for 
Public Comments'' or by using the search function and entering either 
the title of the information collection or the OMB Control Number 1117-
0061. This information collection request may be viewed at 
<a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view Department of Justice, 
information collections currently under review by OMB. If submitting a 
comment, please send a copy of your comment to Heather Achbach to 
<a href="/cdn-cgi/l/email-protection#8dc9c8cca3dddfcccde9e8eca3eae2fb"><span class="__cf_email__" data-cfemail="a8ecede986f8fae9e8cccdc986cfc7de">[email&#160;protected]</span></a>.
    DOJ seeks PRA authorization for this information collection for 
three (3) years. OMB authorization for an ICR cannot be for more than 
three (3) years without renewal. The DOJ notes that information 
collection requirements submitted to the OMB for existing ICRs receive 
a month-to-month extension while they undergo review.
    Abstract: This information collection requires the transferring 
pharmacy to update the electronic prescription record to note that the 
prescription was transferred, and to add the following information: the 
name, address, and DEA registration number of the pharmacy to which the 
prescription was transferred; the name of the pharmacist receiving the 
transfer; the name of the transferring pharmacist; and the date of the 
transfer. The pharmacy receiving the transfer is required to update the 
electronic prescription record with the name, address, and DEA 
registration number of the pharmacy transferring the prescription, the 
name of the transferring pharmacist, the name of the pharmacist 
receiving the transfer, and the date of the transfer.

Overview of This Information Collection

    1. Type of Information Collection: Extension of a previously 
approved collection.
    2. Title of the Form/Collection: Recordkeeping for the Transfer of 
Electronic Prescriptions for Controlled Substances in Schedules II-V 
between Pharmacies for Initial Filling.
    3. Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: No form number is 
associated with this collection. The applicable component within the 
Department of Justice is the Drug Enforcement Administration, Diversion 
Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract: Affected Public: (Primary) Business or other 
for-profit.
    5. Obligation to Respond: Mandatory, 21 U.S.C. 827 and 958.
    6. Total Estimated Number of Respondents: The DEA estimates that 
66,088 registrants participate in this information collection.
    7. Estimated Time per Respondent: The time per response is 3 
minutes for the recordkeeping.
    8. Frequency: As needed, Annual.
    9. Total Estimated Annual Time Burden: 645,000 hours.
    10. Total Estimated Annual Other Costs Burden: $0.

----------------------------------------------------------------------------------------------------------------
                                                                                     Time per
            Activity                 Number of       Frequency     Total annual      response      Total annual
                                    respondents                      responses        (hours)     burden (hours)
----------------------------------------------------------------------------------------------------------------
Transfer of EPCS................          66,088       195.19429      12,900,000            0.05         645,000
                                 -------------------------------------------------------------------------------
    Unduplicated Totals.........          66,088               0      12,900,000            0.05         645,000
----------------------------------------------------------------------------------------------------------------

    If additional information is required, contact: Darwin Arceo, 
Department Clearance Officer, Enterprise Portfolio Management, Justice 
Management Division, United States Department of Justice, Two 
Constitution Square, 145 N Street NE, 4W-218, Washington, DC 20530.

    Dated: September 29, 2026.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2026-20115 Filed 9-30-26; 8:45 am]
BILLING CODE 4410-09-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on October 1, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.